4.5 Review

In Vivo MRI Cell Tracking: Clinical Studies

Journal

AMERICAN JOURNAL OF ROENTGENOLOGY
Volume 193, Issue 2, Pages 314-325

Publisher

AMER ROENTGEN RAY SOC
DOI: 10.2214/AJR.09.3107

Keywords

cell tracking; immunotherapy; molecular imaging; stem cell therapy; superparamagnetic iron oxide

Funding

  1. NIBIB NIH HHS [R21 EB005252-04, R01 EB007825, R01 EB007825-03, R21 EB005252] Funding Source: Medline
  2. NIDA NIH HHS [R01 DA026299, R01 DA02699, R01 DA026299-02] Funding Source: Medline
  3. NINDS NIH HHS [R01 NS045062, R01 NS045062-06A2] Funding Source: Medline

Ask authors/readers for more resources

OBJECTIVE. The purpose of this review is to describe the principles of MRI cell tracking with superparamagnetic iron oxides and the four clinical trials that have been performed. CONCLUSION. Clinical MRI cell tracking is likely to become an important tool at the bedside once (stem) cell therapy becomes mainstream. The most prominent role of this technique probably will be verification of accurate cell delivery with MRI-guided injection, in which interventional radiologists will play a role in the near future. All clinical studies described as of this writing have been performed outside the United States.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available